Henry Nasrallah Award for Excellence in Clinical Psychopharmacology Education
Nominee Eligibility and Award Criteria
This award will be given annually to recognize outstanding contributions in clinical psychopharmacology education and teaching. 2025 will mark its inaugural year. This award will be given annually to recognize outstanding contributions in clinical psychopharmacology education and teaching. 2025 will mark its inaugural year. The nominee should be full member of ASCP and be recognized as an educator nationally and internationally as evidenced by invited CME accredited presentations at national and international conferences.
The Henry Nasrallah award consists of a $3,500 award amount ($2,500 honoraria provided to the award recipient plus $1,000 to cover travel expenses of the award winner). This award will be presented during the 2025 ASCP Annual Meeting (formerly NCDEU) on May 27-May 30, 2025 in Scottsdale, AZ. The Award Winner must attend the 2025 ASCP Annual Meeting.
About Dr. Henry Nasrallah
Position
Dr. Henry Nasrallah is an internationally recognized psychiatrist, educator, and researcher. He received his BS and MD from the American University of Beirut and completed his residency at the University of Rochester, followed by a neuroscience fellowship at the National Institutes of Health (NIH). Dr. Nasrallah has held prominent faculty positions, including at the University of California, San Diego, and Ohio State University, where he served as Chair of the Department of Psychiatry.
Currently, he is the Director of the Schizophrenia and Neuropsychiatry Programs at the University of Cincinnati, where his research focuses on the neurobiology and psychopharmacology of schizophrenia and related disorders. Dr. Nasrallah has authored over 450 scientific articles and 13 books, edited several leading journals, and is a co-founder of the Schizophrenia International Research Society (SIRS).
This award is intended to honor those who exemplify the spirit of Dr. Nasrallah’s commitment to excellence in education and research in clinical psychopharmacology.